Hospira recalls Marcaine; Greenstone recalls venlafaxine; WHO data shows ties between APIs and impurities;

> Canadian medical marijuana producers says that Health Canada is looking to them to follow the similar standards of manufacturing, distribution and vigilance as those imposed on the pharmaceutical industry. Story

> A newly-released review of World Health Organization data shows that the most common manufacturing deficiencies reported were tied to how specific manufacturing process and active pharmaceutical ingredients affect the API impurities content. Report

> Hospira ($HSP) is voluntarily recalling a single lot of its of 0.5% Marcaine injected product. Announcement

> Greenstone is recalling more than 16,000 bottles of venlafaxine HCl extended-release capsules after a pharmacist reported finding another kind of capsule in a bottle. Announcement

> Pharmakon Pharmaceuticals of Noblesville, IN, is recalling 80 syringes of midazolam 0.2 mg/2 mL 0.9% sodium chloride because they contain double their marked dosage. Report

And Finally... The FDA has made improvements to its drug shortages website. See the website here